April Bio
Chuncheon
About April Bio
April Bio is a drug development company that develops antibodies and long-acting biologics.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $46.9M
- Funding stage: IPO
- Last round: Series C (Aug 2021)
- Ticker: kosdaq:397030
- Website: aprilbio.com
- Phone: +82 02 6956 8383
Industries & Categories
Biopharma, Biotechnology, Pharmaceutical
Canonical: https://fsome.com/organization/april-bio-35691 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.